Evidence map›Paper›PMID 42694768›Full record

ReviewChemical science2026

Recent advances in designing high-performance and enzymatically degradable plastics.

Jiaxiong Liu, Xin Zhou, Hiroshi Uyama, Yoshinori Takashima

Abstract readReview
In one paragraph

Review in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiaxiong LiuDepartment of Macromolecular Science, Graduate School of Science, The University of Osaka 1-1 Machikaneyama Toyonaka Osaka 560-0043 Japan takasima@chem.sci.osaka-u.ac.jp.ORCID https://orcid.org/0009-0001-3122-2912
Xin ZhouDepartment of Macromolecular Science, Graduate School of Science, The University of Osaka 1-1 Machikaneyama Toyonaka Osaka 560-0043 Japan takasima@chem.sci.osaka-u.ac.jp.
Hiroshi UyamaDivision of Applied Chemistry, Graduate School of Engineering, The University of Osaka 2-1 Yamadaoka Suita Osaka 565-0871 Japan uyama@chem.eng.osaka-u.ac.jp.ORCID https://orcid.org/0000-0002-8587-2507
Yoshinori TakashimaDepartment of Macromolecular Science, Graduate School of Science, The University of Osaka 1-1 Machikaneyama Toyonaka Osaka 560-0043 Japan takasima@chem.sci.osaka-u.ac.jp.ORCID https://orcid.org/0000-0002-2620-3266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plastics have become indispensable in modern life, yet their end-of-life waste continues to accumulate, causing severe environmental pollution and posing risks to ecosystems and human health. This urgent challenge has driven the development of sustainable plastics as alternatives to conventional persistent plastics, among which biodegradable plastics are particularly promising. Owing to their reduced environmental footprint and their ability to undergo mild biodegradation mediated by efficient enzymes, biodegradable plastics have attracted increasing attention from both academia and industry in recent years. Nevertheless, their practical implementation remains constrained by the persistent trade-off between material performance and degradability. Therefore, the rational design of biodegradable plastics that simultaneously combine high performance and enzymatic degradability is essential for improving their practicality and sustainability, thereby alleviating plastic pollution and advancing a circular plastics economy. In this review, we discuss recent advances, mainly since 2020, in achieving high-performance and enzymatically degradable plastics through chemical design, physical blending, and supramolecular interactions.

Identifiers

PMID42694768
PMCPMC13539503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.